The Search of New Cancer Biomarkers: Moving Forward
نویسندگان
چکیده
منابع مشابه
The search for new prostate cancer biomarkers continues.
Reports published in top-ranked scientific journals frequently draw public media attention. A recent report in Nature by a stellar group of investigators, led by Arul M. Chinnaiyan from the University of Michigan, raises hopes that their discovery may provide a better understanding of prostate cancer progression and may contribute to noninvasive detection or prognostic evaluation of prostate ca...
متن کاملMoving Forward in Human Cancer Risk Assessment
BACKGROUND The current safety paradigm for assessing carcinogenic properties of drugs, cosmetics, industrial chemicals, and environmental exposures relies mainly on in vitro genotoxicity testing followed by 2-year rodent bioassays. This testing battery is extremely sensitive but has low specificity. Furthermore, rodent bioassays are associated with high costs, high animal burden, and limited pr...
متن کاملMoving forward in HIV-associated cancer.
Cancer has been linked to HIV since the earliest days of the epidemic. The unusually frequent occurrence of Kaposi sarcoma (KS) among men who have sex with men (MSM) in 1981 was a sentinel observation leading to the inclusion of KS in the first AIDS case definition. More than three decades later, major research investments have led to striking advances in understanding HIV pathogenesis, with an...
متن کاملA review on miRNAs as new biomarkers for colorectal cancer
Background & Objective: Since colorectal cancer does not often have phenotypic symptoms in the early stages, the study of biomarkers for the diagnosis and prognosis of the tumor is very important. MicroRNAs are one of the most important biomarkers which attract the attention of many researchers due to a variety of reasons, including their non-invasive nature; these molecules are a group of non-...
متن کاملAdjunctive Therapy of Gastric Cancer: Moving the Field Forward.
Despite a decrease in incidence, gastric cancer continues to be the third leading cause of cancer-related death worldwide.[1] For localized disease, surgery offers the best chance for cure. Despite surgery with curative intent, however, many patients experience recurrences, leading to dismal outcomes. With the goal of improving survival, neoadjuvant and adjuvant therapies have emerged. However,...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Clinical Trials
سال: 2013
ISSN: 2167-0870
DOI: 10.4172/2167-0870.1000e114